Timo Minssen
机构: Law Professor, CeBIL Director, University of Copenhagen; Research Affiliate, University of Cambridge
主页: ku.dk
每年引用次数
引用次数
引用: 2,933
H-指数: 22
I10-指数 : 50
出版物: 226
Res Judicata in the Court of Justice Case-Law: Balancing Legal Certainty with Legality?
Xavier Groussot , Timo Minssen
European Constitutional Law Review 3 ( 3) 385 -417
15
2007
ELSI Implications of Prioritizing Biological Therapies in Times of COVID-19
Louise C. Druedahl , Audrey Lebret , Timo Minssen
Journal of Law, Medicine & Ethics 48 ( 3) 579 -582
2020
Patenting Bioprinting-Technologies in the US and Europe: The Fifth Element in the Third Dimension
Timo Minssen , Marc Mimler
Social Science Research Network
2
2017
Will clinical trial data disclosure reduce incentives to develop new uses of drugs
W Nicholson Price , Timo Minssen
Nature Biotechnology 33 ( 7) 685 -686
3
2015
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
Timo Minssen , Aaron S Kesselheim , Jonathan J Darrow
Nature Biotechnology 37 ( 1) 21 -22
1
2019
Ethical and legal issues of ingestible electronic sensors
Sara Gerke , Timo Minssen , Helen Yu , I. Glenn Cohen
Nature Electronics 2 ( 8) 329 -334
27
2019
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
Sara Gerke , Ariel D. Stern , Timo Minssen
npj Digital Medicine 3 ( 1) 1 -6
13
2020
At the Epicenter of COVID-19-the Tragic Failure of the Global Supply Chain for Medical Supplies.
Sonu Bhaskar , Jeremy Tan , Marcel L. A. M. Bogers , Timo Minssen
Frontiers in Public Health 8 562882
80
2020
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO – Part I: The Association for Molecular Pathology v United States Patent and Trademark Office (AMP v USPTO), United States Court of Appeals, Federal Circuit (NY), 29 July 20111
Timo Minssen , David Nilsson
Queen Mary Journal of Intellectual Property 1 ( 3) 223 -247
4
2011
Enforcing patents in the era of 3D printing
Rosa Maria Ballardini , Marcus Norrgård , Timo Minssen
Journal of Intellectual Property Law & Practice 10 ( 11) 850 -866
4
2015
Innovation and intellectual property policies in European Research Infrastructure Consortia—Part I: The Case of the European Spallation Source ERIC
Helen Yu , Jakob Blak Wested , Timo Minssen
Journal of Intellectual Property Law & Practice 12 ( 5) 384 -397
2017
Reap what you sow!—But what about SPC squatting?
Jens Schovsbo , Ulla Callesen Klinge , Timo Minssen
Journal of Intellectual Property Law & Practice 13 ( 7) 569 -580
2018
Synthetic biology and intellectual property rights: Six recommendations
Timo Minssen , Berthold Rutz , Esther van Zimmeren
Biotechnology Journal 10 ( 2) 236 -241
6
2015
Intellectual property rights, standards and data exchange in systems biology
Esther van Zimmeren , Berthold Rutz , Timo Minssen
Biotechnology Journal 11 ( 12) 1477 -1480
3
2016
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways.
Louise C. Druedahl , Anna Birna Almarsdóttir , Sofia Kälvemark Sporrong , Marie Louise De Bruin
Nature Biotechnology 38 ( 11) 1253 -1256
1
2020
Establishing the International Genetic Discrimination Observatory.
Yann Joly , Gratien Dalpé , Charles Dupras , Bénédicte Bévière-Boyer
Nature Genetics 52 ( 5) 466 -468
6
2020
Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development
Timo Minssen , Ana Nordberg
Infectious Diseases in the New Millennium: Legal and Ethical Challenges; (2018) 111 -136
2
2020
What lurks in the shadows of the openness hyperbole for biopharmaceuticals
R. Neethu , Timo Minssen
Drug Development Research 80 ( 3) 282 -284
2
2019
Social, cultural and economic aspects of antimicrobial resistance.
Timo Minssen , Kevin Outterson , Susan Rogers Van Katwyk , Pedro Henrique D Batista
Bulletin of The World Health Organization 98 ( 12) 823 -824
1
2020
When Does Stand-Alone Software Qualify as a Medical Device in the European Union?—The Cjeu’s Decision in Snitem and What it Implies for the Next Generation of Medical Devices
Timo Minssen , Marc Mimler , Vivian Mak
Medical Law Review 28 ( 3) 615 -624
1
2020
Sara Gerke Prof. Mateo Aboy, PhD, SJD, MBA, IAPP Fellow, CLP, CEng Marcelo Corrales Compagnucci W. Nicholson Price II "Glenn Cohen" "I.G. Cohen" "I. Glenn Cohen" "IG Cohen" "Ivan Glenn Cohen" Ana Nordberg Marcel Bogers Dr. Louise C. Druedahl Ariel Dora Stern Kathleen Liddell Jens Schovsbo Henry Chesbrough Marc Mimler Mauritz Kop Urs Gasser Aaron Kesselheim Jakob Wested Ine Van Hoyweghen Mark Fenwick xavier groussot